Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
Current Portion of Long-Term Debt
Bio Rad Laboratories Inc
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bio Rad Laboratories Inc
NYSE:BIO
|
Current Portion of Long-Term Debt
$487k
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-13%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Current Portion of Long-Term Debt
$4.5B
|
CAGR 3-Years
936%
|
CAGR 5-Years
27%
|
CAGR 10-Years
7%
|
|
Danaher Corp
NYSE:DHR
|
Current Portion of Long-Term Debt
$1.7B
|
CAGR 3-Years
459%
|
CAGR 5-Years
116%
|
CAGR 10-Years
39%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Current Portion of Long-Term Debt
$183.2m
|
CAGR 3-Years
52%
|
CAGR 5-Years
28%
|
CAGR 10-Years
27%
|
|
Agilent Technologies Inc
NYSE:A
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Current Portion of Long-Term Debt
$717m
|
CAGR 3-Years
71%
|
CAGR 5-Years
48%
|
CAGR 10-Years
46%
|
See Also
What is Bio Rad Laboratories Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
487k
USD
Based on the financial report for Mar 31, 2024, Bio Rad Laboratories Inc's Current Portion of Long-Term Debt amounts to 487k USD.
What is Bio Rad Laboratories Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
-13%
Over the last year, the Current Portion of Long-Term Debt growth was -51%. The average annual Current Portion of Long-Term Debt growth rates for Bio Rad Laboratories Inc have been -38% over the past three years , -25% over the past five years , and -13% over the past ten years .